Evoclin

Evoclin is a brand name of clindamycin topical, approved by the FDA in the following formulation(s):

EVOCLIN (clindamycin phosphate - aerosol, foam; topical)

• 
  Manufacturer: STIEFEL LABS INC
  
  Approval date: October 22, 2004
  
  Strength(s): 1% ^[RLD][AT]

Has a generic version of Evoclin been approved?

A generic version of Evoclin has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Evoclin and have been approved by the FDA:

clindamycin phosphate aerosol, foam; topical

• 
  Manufacturer: PERRIGO UK FINCO
  
  Approval date: March 31, 2010
  
  Strength(s): 1% ^[AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Evoclin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Pharmaceutical foam
  Patent 7,141,237
  Issued: November 28, 2006
  Inventor(s): Abram; Albert Zorko & Hunt; Barry Thomas
  Assignee(s): Connetics Australia Pty Ltd.
  The present invention provides various pharmaceutically active topical delivery compositions. In particular, compositions of the present invention are present in a pressurized container comprising a quick-breaking alcoholic foaming agent, such that when the composition is released, i.e., dispensed, from the pressurized container, a quick-breaking temperature sensitive foam is formed. In addition, the present invention provides various aspects related to such compositions, including methods for modulating a foam characteristic, methods for improving the shelf-life of a pharmaceutically active compound, methods for the percutaneous treatment of various diseases, infections, and illnesses, and methods for evaluating foam characteristics.
  
  Patent expiration dates:
  
  
  • January 23, 2024
    
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  



• 
  Pharmaceutical foam
  Patent 7,374,747
  Issued: May 20, 2008
  Inventor(s): Abram; Albert Zorko & Hunt; Barry Thomas
  Assignee(s): Stiefel Research Australia, Pty Ltd.
  The present invention provides various pharmaceutically active topical delivery compositions. In particular, compositions of the present invention are present in a pressurized contained comprising a quick-breaking alcoholic foaming agent, such that when the composition is released, i.e., dispensed, from the pressurized container, a quick-breaking temperature sensitive foam is formed. In addition, the present invention provides various aspects related to such compositions, including methods for modulating a foam characteristic, methods for improving the shelf-life of a pharmaceutically active compound, methods for the percutaneous treatment of various diseases, infections, and illnesses, and methods for evaluating foam characteristics.
  
  Patent expiration dates:
  
  
  • August 9, 2026
    
    ✓ 
    Patent use: TREATMENT OF ACNE VULGARIS
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  

See also...

• Evoclin Consumer Information (Drugs.com)
• Evoclin Foam Consumer Information (Wolters Kluwer)
• Evoclin Consumer Information (Cerner Multum)
• Evoclin Topical Advanced Consumer Information (Micromedex)
• Clindamycin Cream Consumer Information (Wolters Kluwer)
• Clindamycin Foam Consumer Information (Wolters Kluwer)
• Clindamycin Gel Consumer Information (Wolters Kluwer)
• Clindamycin Lotion Consumer Information (Wolters Kluwer)
• Clindamycin Solution Consumer Information (Wolters Kluwer)
• Clindamycin Suppositories Consumer Information (Wolters Kluwer)
• Clindamycin Swab Consumer Information (Wolters Kluwer)
• Clindamycin topical Consumer Information (Cerner Multum)
• Clindamycin vaginal Consumer Information (Cerner Multum)
• Z-Clinz Topical Advanced Consumer Information (Micromedex)
• Clindamycin Topical Advanced Consumer Information (Micromedex)
• Clindamycin Vaginal Advanced Consumer Information (Micromedex)
• Clindamycin Phosphate topical AHFS DI Monographs (ASHP)